Michael S. Hearne

Officer, Odonate Therapeutics, Inc.

Companies

Aurinia Pharmaceuticals Inc.Chief financial officer Apr 2, 2026 to now¹
La Jolla Pharmaceutical CompanyOfficer Jun 4, 2020 to Aug 24, 2022²
La Jolla Pharmaceutical CompanyChief financial officer Jun 3, 2020 to Aug 24, 2022³
Odonate Therapeutics, Inc.Officer Dec 10, 2018 to Nov 19, 2021⁴
Odonate Therapeutics, Inc.Chief financial officer Nov 29, 2018 to Mar 17, 2021⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aurinia Pharmaceuticals Inc. AUPH116,144 shares⁶$1.9M at $16.51May 18, 2026
La Jolla Pharmaceutical Company0 shares⁷Aug 22, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

May 18, 2026Granted 116,144 shares of Aurinia Pharmaceuticals Inc.⁶
Aug 22, 2022U 9,607,934 shares at $6.23 of La Jolla Pharmaceutical Company⁷
Aug 22, 2022Returned to company 10,186 shares at $6.23 of La Jolla Pharmaceutical Company⁷
Aug 22, 2022U 9,607,934 shares at $6.23 of La Jolla Pharmaceutical Company⁸
Jun 30, 2022Granted 236 shares at $2.71 of La Jolla Pharmaceutical Company⁹
Jun 15, 2022Granted 236 shares at $2.72 of La Jolla Pharmaceutical Company¹⁰
May 31, 2022Granted 189 shares at $3.41 of La Jolla Pharmaceutical Company¹¹
May 13, 2022Granted 188 shares at $3.41 of La Jolla Pharmaceutical Company¹²
Apr 29, 2022Granted 185 shares at $3.47 of La Jolla Pharmaceutical Company¹³
Apr 14, 2022Granted 173 shares at $3.71 of La Jolla Pharmaceutical Company¹⁴
Mar 31, 2022Granted 177 shares at $3.63 of La Jolla Pharmaceutical Company¹⁵
Mar 15, 2022Granted 190 shares at $3.37 of La Jolla Pharmaceutical Company¹⁶
Feb 28, 2022Granted 185 shares at $3.48 of La Jolla Pharmaceutical Company¹⁷
Feb 15, 2022Granted 169 shares at $3.79 of La Jolla Pharmaceutical Company¹⁸
Jan 31, 2022Granted 1,675 shares at $3.94 of La Jolla Pharmaceutical Company¹⁹
Jan 14, 2022Granted 148 shares at $4.18 of La Jolla Pharmaceutical Company²⁰
Dec 30, 2021Granted 157 shares at $3.92 of La Jolla Pharmaceutical Company²¹
Dec 15, 2021Granted 173 shares at $3.58 of La Jolla Pharmaceutical Company²²
Nov 30, 2021Granted 186 shares at $3.32 of La Jolla Pharmaceutical Company²³
Nov 15, 2021Granted 181 shares at $3.41 of La Jolla Pharmaceutical Company²⁴
Oct 29, 2021Granted 181 shares at $3.42 of La Jolla Pharmaceutical Company²⁵
Oct 15, 2021Granted 183 shares at $3.37 of La Jolla Pharmaceutical Company²⁶
Sep 30, 2021Granted 182 shares at $3.39 of La Jolla Pharmaceutical Company²⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAurinia Pharmaceuticals Inc., Chief financial officer
2
SEC EDGARLa Jolla Pharmaceutical Company, Officer
3
SEC EDGARLa Jolla Pharmaceutical Company, Chief financial officer
4
SEC EDGAROdonate Therapeutics, Inc., Officer
5
SEC EDGAROdonate Therapeutics, Inc., Chief financial officer
6
SEC EDGARAurinia Pharmaceuticals Inc. shares after the filing of May 18, 2026
7
SEC EDGARLa Jolla Pharmaceutical Company shares after the filing of Aug 22, 2022
8
SEC EDGARForm 4 filed Aug 24, 2022
9
SEC EDGARForm 4 filed Jul 5, 2022
10
SEC EDGARForm 4 filed Jun 17, 2022
11
SEC EDGARForm 4 filed Jun 2, 2022
12
SEC EDGARForm 4 filed May 17, 2022
13
SEC EDGARForm 4 filed May 3, 2022
14
SEC EDGARForm 4 filed Apr 18, 2022
15
SEC EDGARForm 4 filed Apr 4, 2022
16
SEC EDGARForm 4 filed Mar 17, 2022
17
SEC EDGARForm 4 filed Mar 2, 2022
18
SEC EDGARForm 4 filed Feb 17, 2022
19
SEC EDGARForm 4 filed Feb 2, 2022
20
SEC EDGARForm 4 filed Jan 19, 2022
21
SEC EDGARForm 4 filed Jan 4, 2022
22
SEC EDGARForm 4 filed Dec 17, 2021
23
SEC EDGARForm 4 filed Dec 2, 2021
24
SEC EDGARForm 4 filed Nov 17, 2021
25
SEC EDGARForm 4 filed Nov 2, 2021
26
SEC EDGARForm 4 filed Oct 19, 2021
27
SEC EDGARForm 4 filed Oct 4, 2021